|
Pharmaceutical Lobby
The pharmaceutical lobby refers to the representatives of pharmaceutical drug and biomedicine companies who engage in lobbying in favour of pharmaceutical companies and their products. Political influence in the United States The largest pharmaceutical companies and their two trade groups, Pharmaceutical Research and Manufacturers of America (PhRMA) and Biotechnology Innovation Organization, lobbied on at least 1,600 pieces of legislation between 1998 and 2004. According to the non-partisan OpenSecrets, pharmaceutical companies spent $900 million on lobbying between 1998 and 2005, more than any other industry. During the same period, they donated $89.9 million to federal candidates and political parties, giving approximately three times as much to Republicans as to Democrats. According to the Center for Public Integrity, from January 2005 through June 2006 alone, the pharmaceutical industry spent approximately $182 million on federal lobbying in the United States. In 2005, the in ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
RAND Corporation
The RAND Corporation (from the phrase "research and development") is an American nonprofit global policy think tank created in 1948 by Douglas Aircraft Company to offer research and analysis to the United States Armed Forces. It is financed by the Federal government of the United States, U.S. government and private Financial endowment, endowment, corporations, university, universities and private individuals. The company assists other governments, international organizations, private companies and foundations with a host of defense and non-defense issues, including healthcare. RAND aims for interdisciplinary and quantitative problem solving by translating theory, theoretical concepts from formal economics and the Outline of physical science, physical sciences into novel applications in other areas, using applied science and operations research. Overview RAND has approximately 1,850 employees. Its American locations include: Santa Monica, California (headquarters); Arlington ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
Conflict Of Interest
A conflict of interest (COI) is a situation in which a person or organization is involved in multiple interests, financial or otherwise, and serving one interest could involve working against another. Typically, this relates to situations in which the personal interest of an individual or organization might adversely affect a duty owed to make decisions for the benefit of a third party. An "interest" is a commitment, obligation, duty or goal associated with a particular social role or practice. By definition, a "conflict of interest" occurs if, within a particular decision-making context, an individual is subject to two coexisting interests that are in direct conflict with each other. Such a matter is of importance because under such circumstances the decision-making process can be disrupted or compromised in a manner that affects the integrity or the reliability of the outcomes. Typically, a conflict of interest arises when an individual finds themselves occupying two soc ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
Amy Goodman
Amy Goodman (born April 13, 1957) is an American broadcast journalist, syndicated columnist, investigative reporter, and author. Her investigative journalism career includes coverage of the East Timor independence movement, Morocco's occupation of Western Sahara, and Chevron Corporation's role in Nigeria. Since 1996, she has been the main host of ''Democracy Now!'', a progressive global news program broadcast daily on radio, television and the Internet. She has received awards for her work, including the Thomas Merton Award in 2004, a Right Livelihood Award in 2008, and an Izzy Award in 2009 for "special achievement in independent media". In 2012, Goodman received the Gandhi Peace Award for a "significant contribution to the promotion of an enduring international peace". She is the author of six books, including the 2012 ''The Silenced Majority: Stories of Uprisings, Occupations, Resistance, and Hope,'' and the 2016 ''Democracy Now!: Twenty Years Covering the Movements Changing ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
Pharmaceutical Marketing
Many countries have measures in place to limit advertising by pharmaceutical companies. Pharmaceutical company spending on marketing generally exceeds that of its research budget. In Canada, $1.7 billion was spent in 2004 to market drugs to physicians; in the United States, $21 billion was spent in 2002. In 2005, money spent on pharmaceutical marketing in the United States was estimated at $29.9 billion with one estimate as high as $57 billion. When the U.S. numbers are broken down, 56% was free samples, 25% was pharmaceutical sales representative "detailing" (promoting drugs directly to) physicians, 12.5% was direct to user advertising, 4% on detailing to hospitals, and 2% on journal ads. There is some evidence that marketing practices can negatively affect both patients and the health care profession. To health care providers Marketing to health-care providers takes three main forms: activity by pharmaceutical sales representatives, provision of drug samples, and sponsoring ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
Lists About The Pharmaceutical Industry
These are Wikipedia lists about the pharmaceutical industry. The pharmaceutical industry develops, produces, and markets drugs or pharmaceuticals licensed for use as medications. Pharmaceutical companies are allowed to deal in generic or brand medications and medical devices. They are subject to a variety of laws and regulations regarding the production, testing, and marketing of drugs. *List of pharmaceutical companies * List of largest selling pharmaceutical products *List of largest pharmaceutical settlements *List of off-label promotion pharmaceutical settlements * List of pharmaceutical sciences journals *List of pharmaceutical compound number prefixes *List of pharmaceutical manufacturers in the United Kingdom This is a list of manufacturers and suppliers of pharmaceuticals with operations in the United Kingdom. Note: the activities of the parent companies of many of the companies listed below are not restricted solely to the United Kingdom. For example ... * List of pha ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
List Of Pharmaceutical Companies
This listing is limited to those independent companies and subsidiaries notable enough to have their own articles in Wikipedia. Both going concerns and defunct firms are included, as well as firms that were part of the pharmaceutical industry at some time in their existence. Included here are companies engaged not only in pharmaceutical development, but also supply chain management and device development, including compounding pharmacies. Retail pharmacies; firms specialized in the collection, fractionation and distribution of human blood; and medical device manufacturers where the device is not related to pharmaceutical administration are not included. Entry titles have been shortened in a number of cases, so that if the article title of a company is "XYZ Pharma", for instance, the entry will appear here as "XYZ". Companies which existed as a joint venture for their entire existence are indicated by a super-script "JV", as in PerseidJV. Alphabetical listing—Active firms ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
Ethics In Pharmaceutical Sales
The ethics involved within pharmaceutical sales is built from the organizational ethics, which is a matter of system compliance, accountability and culture (Grace & Cohen, 2005). Organizational ethics are used when developing the marketing and sales strategy to both the public and the healthcare profession of the strategy. Organizational ethics are best demonstrated through acts of fairness, compassion, integrity, honor, and responsibility. Industry The pharmaceutical industry is a highly competitive business and its success is dependent on the sales and marketing of each drug. The cost of research and development for each drug is hundreds of millions of dollars. In 2005 the research and development expenditure for the biopharmaceutical industry within Europe and the US was 15,474 million euro.(The Pharma Industry Figures, 2006). Some health economists peg the current cost of drug development at US$1.3 billion, others at US$1.7 billion The actual drug discovery and the drug develop ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
Big Pharma Conspiracy Theory
Big Pharma conspiracy theories are conspiracy theories which claim that the medical community in general and pharmaceutical companies in particular, especially large corporations, operate for sinister purposes and against the public good, that they conceal effective treatments, or even cause and worsen a wide range of diseases for the purpose of profitability, or for other nefarious reasons. Some theories have included the claim that natural alternative remedies to health problems are being suppressed, the claim that drugs for the treatment of HIV/AIDS are ineffective and harmful, the claim that a cure for all cancers has been discovered but hidden from the public, claims that COVID-19 vaccines are ineffective, and that alternative cures are available for COVID-19. In each case the conspiracy theorists have blamed pharmaceutical companies' search for profits. A range of authors have shown these claims to be false, though some of these authors nevertheless maintain that other crit ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
Big Pharma (book)
: ''Big Pharma may also refer to the pharmaceutical lobby.'' ''Big Pharma: How the World's Biggest Drug Companies Control Illness'' is a 2006 book by British journalist Jacky Law. The book examines how major pharmaceutical companies determine which health care problems are publicised and researched. Outlining the history of the pharmaceutical industry, Law identifies what she says is the failure of a regulatory framework that assumes pharmaceutical companies always produce worthwhile products that society will want. Law has written about healthcare for 25 years, seven of them as associate editor of ''Scrip Magazine'', a monthly magazine for the drugs industry. Reception Ike Iheanacho writes about the book that "The author is clearly no great fan of the industry. But, refreshingly, she avoids the sort of lazy polemic that casts major pharmaceutical companies as an evil empire that continually foists its products on unwilling and unsuspecting healthcare professionals and patien ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
Ben Goldacre
Ben Michael Goldacre (born 20 May 1974) is a British physician, academic and science writer. He is the first Bennett Professor of Evidence-Based Medicine and director of the Bennett Institute for Applied Data Science at the University of Oxford. He is a founder of the AllTrials campaign and OpenTrials to require open science practices in clinical trials. Goldacre is known in particular for his ''Bad Science'' column in ''The Guardian'', which he wrote between 2003 and 2011, and is the author of four books: '' Bad Science'' (2008), a critique of irrationality and certain forms of alternative medicine; '' Bad Pharma'' (2012), an examination of the pharmaceutical industry, its publishing and marketing practices, and its relationship with the medical profession; ''I Think You'll Find It's a Bit More Complicated Than That'', a collection of his journalism; and ''Statins'', about evidence-based medicine. Goldacre frequently delivers free talks about bad science; he describes himself ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
Bad Pharma
''Bad Pharma: How Drug Companies Mislead Doctors and Harm Patients'' is a book by the British physician and academic Ben Goldacre about the pharmaceutical industry, its relationship with the medical profession, and the extent to which it controls academic research into its own products.Luisa Dillner"Bad Pharma by Ben Goldacre – review" ''The Guardian'', 17 October 2012. It was published in the UK in September 2012 by the Fourth Estate imprint of HarperCollins, and in the United States in February 2013 by Faber and Faber. Goldacre argues in the book that "the whole edifice of medicine is broken", because the evidence on which it is based is systematically distorted by the pharmaceutical industry. He writes that the industry finances most of the clinical trials into its own products and much of doctors' continuing education, that clinical trials are often conducted on small groups of unrepresentative subjects and negative data is routinely withheld, and that apparently independe ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
.JPG "Click for more on -> Bad Pharma")